This guideline describes following points;
This guideline is to ensure that the PIL is written in clear and intelligible terms for the patient and is clearly legible.
This guideline describes the following points;
South African Health Products Regulatory Authority (SAHPRA) regulates medicines, scheduled
substances and medical devices for human and animal use, on behalf of the Department of Health and
in accordance with the provisions of the Medicines and Related Substances Act, 1965 (Act 101 of
1965) and the relevant Regulations made thereunder. (Hereafter referred to as the Act or the
Medicines Act.)
This guideline describes the following points;
The aim of this Guideline is to assist wholesalers in the preparation of documentation for the application
to be licensed to export medicinal products Whenever there is doubt, wholesalers are advised to consult
South African Health Products Regulatory Authority (SAHPRA) for confirmation and/or clarification before
completing and submitting an application.
This guideline applies to all wholesalers who are intending to export medicinal products.
this guideline describes the following points;
South African Health Products Regulatory Authority (SAHPRA) is a statutory body, appointed by the Minister of Health to register medicines, and to ensure that these medicines are of quality, safe and efficacious. Medicines registered by SAHPRA, should, during their entire life cycle, comply with the information that has been evaluated and approved by SAHPRA.
All GMP inspections are carried out in accordance with the approved procedure to ensure compliance with the SA Guide to GMP, PIC/S guidelines on GMP, and WHO Guide to GMP.
Wholesaler distribution forms part of the supply chain of pharmaceutical products manufactured. Wholesalers are responsible for the effective, efficient and safe handling, storage, and distribution of such products ensuring the quality and identity of these during all aspects of the wholesaling and distribution process. This Guideline sets out appropriate steps for meeting this responsibility.
This guideline describes the following points;
The South African Health Products Regulatory Authority (SAHPRA) regulates medicines, scheduled substances, and medical devices for human and animal use, in accordance with the provisions of the Medicines and Related Substances Act, 1965 (Act 101 of 1965) and
the relevant Regulations made thereunder. (Hereafter referred to as the Act or the Medicines Act.)
This guideline is to clarify the provisions of the Act that allow for exemptions from certain requirements and to encourage applicants to register much-needed medicines for which the regulatory burden may be perceived as being too high e.g. minor use minor species.